SCHEMBL15977111

SCHEMBL15977111

Cc1ccccc1Nc1nc(Nc2cc(C)c(C3CCN(C)CC3)cc2OC(C)C)ncc1C

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALK Q9UM73 20/20 0.79
▸ INSR P06213 17/20 0.79
▸ KCNH2 Q12809 6/20 0.79
▸ NPM1 P06748 6/20 0.60
▸ CYP3A4 P08684 2/20 0.59
▸ ABL1 P00519 1/20 0.57
▸ EGFR P00533 1/20 0.57
▸ ERBB2 P04626 1/20 0.57
▸ LCK P06239 1/20 0.57
▸ RET P07949 1/20 0.57
▸ IGF1R P08069 1/20 0.57
▸ MET P08581 1/20 0.57
▸ PDGFRA P16234 1/20 0.57
▸ CDK2 P24941 1/20 0.57
▸ AKT1 P31749 1/20 0.57
▸ KDR P35968 1/20 0.57
▸ GSK3B P49841 1/20 0.57
▸ PLK1 P53350 1/20 0.57
▸ EPHB4 P54760 1/20 0.57
▸ BTK Q06187 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1546085 0.89 ALK (1.00) ALKINSRKCNH2NPM1CYP3A4
SCHEMBL19372638 0.88 ALK (0.68) ALKINSRKCNH2NPM1ABL1
SCHEMBL17703353 0.88 ALK (0.82) ALKINSRKCNH2NPM1ABL1
SCHEMBL14109978 0.87 ALK (0.88) ALKINSRKCNH2NPM1CYP3A4
SCHEMBL12236962 0.86 ALK (0.70) ALKINSRKCNH2NPM1CYP3A4
SCHEMBL12236849 0.86 ALK (0.70) ALKINSRKCNH2NPM1CYP3A4
SCHEMBL12240877 0.86 ALK (0.70) ALKINSRKCNH2NPM1CYP3A4
SCHEMBL14109980 0.86 ALK (0.81) ALKINSRKCNH2NPM1CYP3A4
SCHEMBL12236845 0.85 ALK (0.68) ALKINSRKCNH2NPM1CYP3A4
SCHEMBL12236963 0.85 ALK (0.68) ALKINSRKCNH2NPM1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3012249-A1 COMPOUNDS AND COMPOSITION AS PROTEIN KINASE INHIBITORS Novartis AG (CH) 2016-04-27 — — EP disclosed
EP-2091918-B1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2014-08-27 — — EP disclosed
Send feedback